Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Seattle VA Medical Center is seeking information on the procurement of rapid syndromic molecular testing reagents through a sources sought notice issued under solicitation number 36C26026Q0905. The requirement is aimed at acquiring reagents used for fast and accurate diagnostic testing of infectious syndromes to support clinical care at the facility, with performance located in Seattle, Washington. The request is hosted by the 260-NETWORK Contract Office 20 under the Department of Veterans Affairs, and responses are due by August 6, 2027. No set-aside provisions are being applied, and the NAICS code 325413 indicates this relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Hector D. Baltazar, with James Harris listed as a secondary contact. All details regarding technical specifications, volumes, and performance requirements are contained in the accompanying attachments, with interested parties encouraged to review them before submitting responses.
General Info
Agency
NAICS
Place of Performance
Seattle, WA, 98108, USASet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Procurement of rapid syndromic molecular testing reagents for the Seattle VA Medical Center. Please see Attachments for further information in regards to this acquisition.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → 260-NETWORK Contract Office 20 (36C260)
Same awarding agency
